ラマトロバンのスギ花粉症に対する有効性  [in Japanese] Clinical Efficacy of Ramatroban on Japanese Cedar Pollinosis  [in Japanese]

Access this Article

Author(s)

Abstract

The clinical efficacy of ramatroban, a thromboxane A<sub>2</sub> receptor antagonist, was investigated in 48 patients who consulted Masutani ENT Clinic in Osaka between January and May, 2001. Medication was administered and groups were stratified by start time.<br>In the peak period for Japanese cedar pollen scattering, the pre-treatment group demonstrated better control of nasal symptoms (sneeze, nasal mucus, and nasal obstruction) than the group that started the medication after Japanese cedar pollen scattering started.<br>Nasal obstruction has also improved by the medication for two weeks in patients who consulted the hospital with nasal obstruction after Japanese cedar and cypress pollen scattering had ended.<br>There were no side effects in any patients during ramatroban treatment.<br>Therefore, ramatroban was considered to be an effective medicine also not only for patients with perennial allergic rhinitis but also for patients with seasonal allergic rhinitis. It was thought that the nasal symptom of the pollen scattering period could be controlled by pre-treatment.

Journal

  • Practica Oto-Rhino-Laryngologica

    Practica Oto-Rhino-Laryngologica 95(5), 539-550, 2002-05-01

    The Society of Practical Otolaryngology

References:  11

Codes

  • NII Article ID (NAID)
    10008382876
  • NII NACSIS-CAT ID (NCID)
    AN00107089
  • Text Lang
    JPN
  • Article Type
    ART
  • ISSN
    00326313
  • NDL Article ID
    6154927
  • NDL Source Classification
    ZS43(科学技術--医学--耳鼻咽喉科学)
  • NDL Call No.
    Z19-421
  • Data Source
    CJP  NDL  J-STAGE 
Page Top